| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
-0.02 |
0.9 |
| mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.0099 |
0.9 |